[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Webmail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 36, Issue 3 (Fall 2026) ::
MEDICAL SCIENCES 2026, 36(3): 302-311 Back to browse issues page
Development and validation of a high performance liquid chromatographic (HPLC) method for simultaneous determination of Linagliptin and Metformin in tablet
Melika Bagheri1 , Ensieh Ghasemi2
1- Department of Pharmaceutical Chemistry, TeMS.C., Islamic Azad Univeresity, Tehran, Iran
2- Associate Professor, Department of Pharmaceutical Chemistry, TeMS.C., Islamic Azad Univeresity, Tehran, Iran , ghasemi.elahe@gmail.com
Abstract:   (4 Views)
Background: The combination of metformin, a first-line biguanide, and linagliptin, a DPP-4 inhibitor that reduces GLP and GIP degradation, improves insulin secretion, decreases glucagon production, and effectively controls blood glucose and HbA1c levels in patients with type diabetes. This study aimed to develop and validate a simple, rapid, accurate, and sensitive method for the simultaneous determination of metformin and linagliptin in tablet dosage forms.
Materials and methods: Simultaneous analysis was performed using ion chromatography with sodium lauryl sulfate as an ionic reagent. Chromatographic conditions were optimized. Peak separation and symmetry were evaluated using resolution and tailing factors. The method was validated for specificity, linearity, accuracy, precision, repeatability, detection limit, quantification limit, and robustness.
Results: Optimal separation was achieved using a C18 column (4.6 × 150 mm, 5 µm) with a mobile phase of methanol: acetonitrile: 0/02 M potassium hydrogen phosphate (10:35:55, pH 4.6), at 218 nm and a flow rate of 1 mL/min. Linearity was observed for metformin (0.11–0.66 µg/mL) and linagliptin (0.00054–0.00324 µg/mL). Retention times were 3.7 and 2.2 minutes, respectively.
Conclusion: The validated method demonstrated satisfactory accuracy, precision, and robustness and is suitable for routine quality control analysis of metformin and linagliptin tablets. Overall, this method offers a reliable and efficient analytical approach for the simultaneous determination of both drugs in combined pharmaceutical formulations.
 
Keywords: Metformin, Linagliptin, Liquid chromatography, Ionic reagent, Development and validation method.
Full-Text [PDF 1039 kb]   (1 Downloads)    
Semi-pilot: Experimental | Subject: Chemistry
Received: 2025/11/15 | Accepted: 2026/01/11 | Published: 2026/09/1
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bagheri M, Ghasemi E. Development and validation of a high performance liquid chromatographic (HPLC) method for simultaneous determination of Linagliptin and Metformin in tablet. MEDICAL SCIENCES 2026; 36 (3) :302-311
URL: http://tmuj.iautmu.ac.ir/article-1-2411-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 36, Issue 3 (Fall 2026) Back to browse issues page
فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch
Persian site map - English site map - Created in 0.18 seconds with 37 queries by YEKTAWEB 4774